GL1X · GenesisL1 explorer

Research workbench

Crystal structure of VEGFR2 with a benzimidazole-urea inhibitor

Analyse Crystal structure of VEGFR2 with a benzimidazole-urea inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2OH4
Type
protein
Length
299 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
GIG, SO4
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein29940% helix, 16% strandP35968

Ligands and binding sites

  • GIG · Methyl (5-{4-[({[2-fluoro-5-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-1H-benzimidazol-2-yl)carbamate · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13540.710.8343GIG
21410.400.7426SO4
31090.390.7516SO4

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 2OH4 · Crystal structure of Vegfr2 with a benzimidazole-urea inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P35968 · AlphaFold monomer V2.0 prediction for vascular endothelial growth factor receptor 2… · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.